View in EDS PDF Full Text

A new case with rare e6a2 BCR–ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment.

Saved in:
Bibliographic Details
Title: A new case with rare e6a2 BCR–ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment.
Authors: Schnittger, S.1 susanne.schnittger@mll-online.com, Bacher, U.2, Kern, W.1, Haferlach, T.1, Hertenstein, B.3, Haferlach, C.1
Source: Leukemia (08876924). Apr2008, Vol. 22 Issue 4, p856-858. 3p. 1 Diagram, 1 Chart, 1 Graph.
Database: Academic Search Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 31652245
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A new case with rare e6a2 BCR–ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Schnittger%2C+S%2E%22">Schnittger, S.</searchLink><relatesTo>1</relatesTo><i> susanne.schnittger@mll-online.com</i><br /><searchLink fieldCode="AR" term="%22Bacher%2C+U%2E%22">Bacher, U.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Kern%2C+W%2E%22">Kern, W.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Haferlach%2C+T%2E%22">Haferlach, T.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Hertenstein%2C+B%2E%22">Hertenstein, B.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Haferlach%2C+C%2E%22">Haferlach, C.</searchLink><relatesTo>1</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Leukemia+%2808876924%29%22">Leukemia (08876924)</searchLink>. Apr2008, Vol. 22 Issue 4, p856-858. 3p. 1 Diagram, 1 Chart, 1 Graph.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=31652245
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/sj.leu.2404949
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 3
        StartPage: 856
    Titles:
      – TitleFull: A new case with rare e6a2 BCR–ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schnittger, S.
      – PersonEntity:
          Name:
            NameFull: Bacher, U.
      – PersonEntity:
          Name:
            NameFull: Kern, W.
      – PersonEntity:
          Name:
            NameFull: Haferlach, T.
      – PersonEntity:
          Name:
            NameFull: Hertenstein, B.
      – PersonEntity:
          Name:
            NameFull: Haferlach, C.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: Apr2008
              Type: published
              Y: 2008
          Identifiers:
            – Type: issn-print
              Value: 08876924
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Leukemia (08876924)
              Type: main
ResultId 1